An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
暂无分享,去创建一个
H. K. Raju | G. Weil | P. Jambulingam | S. Swaminathan | A. Srividya | M. Rahi | K. Krishnamoorthy | V. Kuttiatt | R. Somani | Mallanna K Suryaprakash | G. P. Dwivedi